← All Voyager Therapeutics, INC filings

Voyager Therapeutics, INC Form 4 insider transactions

NASDAQ
VYGR
Voyager Therapeutics, INC
Form 4: Voyager Therapeutics Director, Grace Colon, Acquires 24,000 Stock Options
Director Grace Colon acquired 24,000 stock options in Voyager Therapeutics, Inc. on June 5, 2024, according to a Form 4 filing.
NASDAQ
VYGR
Voyager Therapeutics, INC
Form 4: Voyager Therapeutics' Chief Medical Officer, Toby Ferguson, Reports Acquisition of 105,000 Shares
Toby Ferguson, Chief Medical Officer of Voyager Therapeutics, reports acquiring 105,000 shares of common stock on April 1, 2024, as an inducement for employment.
NASDAQ
VYGR
Voyager Therapeutics, INC
Form 4: Voyager Therapeutics COO Robin Swartz Reports Sale of Common Stock for Tax Obligations
Robin Swartz, Chief Operating Officer of Voyager Therapeutics, sold 1,357 shares of common stock on April 2, 2024, to cover tax obligations related to vesting restricted stock units.
NASDAQ
VYGR
Voyager Therapeutics, INC
Form 4: Voyager Therapeutics CEO Alfred Sandrock Sells Shares to Cover Tax Obligations
Voyager Therapeutics CEO Alfred Sandrock sold 12,115 shares of common stock on April 2, 2024, to cover tax obligations related to vesting restricted stock units.
NASDAQ
VYGR
Voyager Therapeutics, INC
Form 4: Voyager Therapeutics Chief Medical Officer Receives Inducement Stock Options
Toby Ferguson, Chief Medical Officer of Voyager Therapeutics, receives 210,000 stock options as an inducement to employment.